Problem

Instalab addresses a gap in preventive healthcare: routine primary-care pathways often stop at basic labs, while people who want to detect disease early or optimize long-term health may struggle to obtain advanced cardiac imaging, hormone panels, genetic tests, microbiome profiles, or multi-cancer screening. The pain is also logistical and interpretive. Patients have to find appropriate clinicians, secure orders, book appointments, and make sense of results; Instalab’s customer testimony specifically describes frustration getting the same tests through a primary-care provider.

The main use case is a busy, health-conscious professional, founder, executive, athlete, or parent who wants a comprehensive snapshot of risk before symptoms appear and a clear plan for acting on it. The economics are primarily cash-pay: Instalab says its transparent prices are below typical insurance-billed rates, with HSA/FSA eligibility and no insurance paperwork. Example offerings include a coronary calcium scan from $99, a 60-plus-biomarker blood panel for $299, and a multi-cancer early-detection test for $849.

Product / Service

Instalab is a consumer-facing preventive-health platform that combines testing, interpretation, physician care, treatments, and longitudinal tracking. Its catalog includes more than 600 lab tests, over 30 imaging studies, and at-home monitoring devices. Customers can order tests directly without a referral; when a physician order is required, Instalab’s clinician network reviews and authorizes it. Blood draws can occur at home or at a patient-service center, other sample kits ship to the customer, and Instalab books imaging at accredited centers.

The platform turns results into an action plan rather than simply returning numbers. Personalized reports explain abnormal markers and possible implications, while optional video consultations with board-certified preventive-medicine and longevity physicians provide recommendations on lifestyle, follow-up testing, and medication when appropriate. The membership and concierge layer adds care coordination, physician access, preferred pricing, and follow-through across tests, medications, supplements, and tracking.

Market

Instalab competes in the growing direct-to-consumer preventive-diagnostics and longevity-care market, sitting between laboratory testing, virtual physician services, executive-health concierge care, and wellness optimization. Its closest known alternatives include Function Health, which offers a subscription with more than 160 lab tests, and Superpower, another subscription-based lab-testing service. InsideTracker is an adjacent competitor focused more heavily on blood-based health intelligence and performance optimization. Instalab differentiates by combining broad diagnostics with physician interpretation, concierge scheduling, treatments, and ongoing monitoring rather than selling testing alone.

The company is not evidently pre-revenue. Instalab’s website reports more than 10,000 patients, while its Y Combinator profile describes it as serving tens of thousands of founders, executives, and professional athletes; YC lists the company as founded in 2022, Winter 2022, and active. A third-party company profile reports $1.5 million of revenue in 2024 and says Instalab bootstrapped, while PitchBook reports $500,000 raised from Y Combinator and Liquid 2 Ventures. The patient and revenue figures should be treated as company-directory or company-claimed indicators rather than audited financial disclosure.